(Q37869910)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21526942%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

review article

1 reference

title

Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21526942%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

Acinetobacter baumannii

1 reference

inferred from title

antimicrobial resistance

1 reference

inferred from title

author

Emanuele Durante-Mangoni

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21526942%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Raffaele Zarrilli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21526942%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Emanuele Durante-Mangoni

1

1 reference

24 August 2017

Raffaele Zarrilli

2

1 reference

24 August 2017

1 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21526942%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

number of pages

16

1 reference

inferred from page(s)

published in

Future Microbiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21526942%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21526942%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21526942%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

407-422

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21526942%20AND%20SRC:MED&resulttype=core&format=json

An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii

30 January 2020

cites work

1 reference

Acinetobacter baumannii: emergence of a successful pathogen

21 January 2018

1 reference

Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region

21 January 2018

1 reference

Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species

21 January 2018

1 reference

gyrB multiplex PCR to differentiate between Acinetobacter calcoaceticus and Acinetobacter genomic species 3.

21 January 2018

1 reference

Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization

21 January 2018

1 reference

Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance

21 January 2018

1 reference

Frequent multidrug-resistant Acinetobacter baumannii contamination of gloves, gowns, and hands of healthcare workers.

21 January 2018

1 reference

Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes

21 January 2018

1 reference

Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology.

21 January 2018

1 reference

Comparative analysis of Acinetobacters: three genomes for three lifestyles

21 January 2018

1 reference

Whole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II group

21 January 2018

1 reference

Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

Genomewide analysis of divergence of antibiotic resistance determinants in closely related isolates of Acinetobacter baumannii

21 January 2018

1 reference

Acinetobacter baumannii 2002-2008: increase of carbapenem-associated multiclass resistance in the United States

21 January 2018

1 reference

Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program

21 January 2018

1 reference

Global spread of carbapenem-resistant Acinetobacter baumannii

21 January 2018

1 reference

Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases

21 January 2018

1 reference

Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii

21 January 2018

1 reference

Genetic structures at the origin of acquisition and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-58 in Acinetobacter baumannii

21 January 2018

1 reference

A plasmid-borne blaOXA-58 gene confers imipenem resistance to Acinetobacter baumannii isolates from a Lebanese hospital.

21 January 2018

1 reference

Characterization of pABVA01, a plasmid encoding the OXA-24 carbapenemase from Italian isolates of Acinetobacter baumannii

21 January 2018

1 reference

OXA-24 carbapenemase gene flanked by XerC/XerD-like recombination sites in different plasmids from different Acinetobacter species isolated during a nosocomial outbreak

21 January 2018

1 reference

Acquisition of a plasmid-borne blaOXA-58 gene with an upstream IS1008 insertion conferring a high level of carbapenem resistance to Acinetobacter baumannii

21 January 2018

1 reference

Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii

21 January 2018

1 reference

Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC beta-lactamase in Acinetobacter baumannii

21 January 2018

1 reference

VEB-1 Extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France

21 January 2018

1 reference

Emergence of PER-2 and VEB-1a in Acinetobacter baumannii Strains in the Americas.

21 January 2018

1 reference

Emergence of PER and VEB extended-spectrum beta-lactamases in Acinetobacter baumannii in Belgium

21 January 2018

1 reference

Spread of bla(CTX-M-type) and bla(PER-2) beta-lactamase genes in clinical isolates from Bolivian hospitals

21 January 2018

1 reference

Characterization of Acinetobacter baumannii carrying bla(OXA-23), bla(PER-1) and armA in a Korean hospital.

21 January 2018

1 reference

Widespread transfer of resistance genes between bacterial species in an intensive care unit: implications for hospital epidemiology

21 January 2018

1 reference

Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase

21 January 2018

1 reference

Nosocomial transmission of CTX-M-2 beta-lactamase-producing Acinetobacter baumannii in a neurosurgery ward

21 January 2018

1 reference

Identification of the novel narrow-spectrum beta-lactamase SCO-1 in Acinetobacter spp. from Argentina

21 January 2018

1 reference

Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India.

21 January 2018

1 reference

OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii

21 January 2018

1 reference

The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii.

21 January 2018

1 reference

Acquisition of resistance to carbapenems in multidrug-resistant clinical strains of Acinetobacter baumannii: natural insertional inactivation of a gene encoding a member of a novel family of beta-barrel outer membrane proteins

21 January 2018

1 reference

Identification of an OprD homologue in Acinetobacter baumannii

21 January 2018

1 reference

Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii

21 January 2018

1 reference

Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii

21 January 2018

1 reference

Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454

21 January 2018

1 reference

Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones.

21 January 2018

1 reference

Widespread occurrence of aminoglycoside resistance due to ArmA methylase in imipenem-resistant Acinetobacter baumannii isolates in China.

21 January 2018

1 reference

Partial characterization of a transposon containing the tet(A) determinant in a clinical isolate of Acinetobacter baumannii

21 January 2018

1 reference

Distribution of tetracycline resistance genes in genotypically related and unrelated multiresistant Acinetobacter baumannii strains from different European hospitals

21 January 2018

1 reference

AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii

21 January 2018

1 reference

Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system

21 January 2018

1 reference

RT-PCR and statistical analyses of adeABC expression in clinical isolates of Acinetobacter calcoaceticus-Acinetobacter baumannii complex

21 January 2018

1 reference

AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii

21 January 2018

1 reference

Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray

21 January 2018

1 reference

Overexpression of resistance-nodulation-cell division pump AdeFGH confers multidrug resistance in Acinetobacter baumannii

21 January 2018

1 reference

AbeM, an H+-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters

21 January 2018

1 reference

Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii

21 January 2018

1 reference

Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii.

21 January 2018

1 reference

Novel gyrA and parC point mutations in two strains of Acinetobacter baumannii resistant to ciprofloxacin

21 January 2018

1 reference

Epidemiology of rifampin ADP-ribosyltransferase (arr-2) and metallo-beta-lactamase (blaIMP-4) gene cassettes in class 1 integrons in Acinetobacter strains isolated from blood cultures in 1997 to 2000.

21 January 2018

1 reference

Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production

21 January 2018

1 reference

Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system

21 January 2018

1 reference

Activation of PmrA inhibits LpxT-dependent phosphorylation of lipid A promoting resistance to antimicrobial peptides

21 January 2018

1 reference

Resistance to disinfectants in epidemiologically defined clinical isolates of Acinetobacter baumannii.

21 January 2018

1 reference

Correlation between reduced susceptibility to disinfectants and multidrug resistance among clinical isolates of Acinetobacter species

21 January 2018

1 reference

Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii

21 January 2018

1 reference

Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii.

21 January 2018

1 reference

Molecular epidemiology of clinical Acinetobacter baumannii and Acinetobacter genomic species 13TU isolates using a multilocus sequencing typing scheme

21 January 2018

1 reference

The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool

21 January 2018

1 reference

Wide dissemination of OXA-23-producing carbapenem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China.

21 January 2018

1 reference

Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a tertiary care hospital in Naples, Italy, shows the emergence of a novel epidemic clone.

21 January 2018

1 reference

Prevalence and diversity of carbapenemases among imipenem-nonsusceptible Acinetobacter isolates in Korea: emergence of a novel OXA-182.

21 January 2018

1 reference

High prevalence of carbapenem-resistant Acinetobacter baumannii carrying the blaOXA-143 gene in Brazilian hospitals.

21 January 2018

1 reference

Susceptibility of acinetobacter strains isolated from deployed U.S. military personnel

21 January 2018

1 reference

Treatment of Acinetobacter infections.

21 January 2018

1 reference

Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant Acinetobacter baumannii around London

21 January 2018

1 reference

Use of Etest MBL strips for the detection of carbapenemases in Acinetobacter baumannii.

21 January 2018

1 reference

Detecting imipenem resistance in Acinetobacter baumannii by automated systems (BD Phoenix, Microscan WalkAway, Vitek 2); high error rates with Microscan WalkAway

21 January 2018

1 reference

Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients

21 January 2018

1 reference

Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

21 January 2018

1 reference

Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study

21 January 2018

1 reference

21 January 2018

1 reference

Treatment of Acinetobacter infections

21 January 2018

1 reference

Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections

21 January 2018

1 reference

Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.

21 January 2018

1 reference

Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients

21 January 2018

1 reference

Steady-state pharmacokinetics and BAL concentration of colistin in critically Ill patients after IV colistin methanesulfonate administration

21 January 2018

1 reference

Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.

21 January 2018

1 reference

Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

21 January 2018

1 reference

Nephrotoxicity of intravenous colistin: a prospective evaluation

21 January 2018

1 reference

Colistin dosing and nephrotoxicity in a large community teaching hospital

21 January 2018

1 reference

Colistin heteroresistance in acinetobacter and its association with previous colistin therapy

21 January 2018

1 reference

High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea.

21 January 2018

1 reference

Selection of colistin-resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin.

21 January 2018

1 reference

Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii

21 January 2018

1 reference

Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections

21 January 2018

1 reference

Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand

21 January 2018

1 reference

Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.

21 January 2018

1 reference

Comprehensive assessment of tigecycline activity tested against a worldwide collection of Acinetobacter spp. (2005-2009).

21 January 2018

1 reference

In vitro activity of tigecycline and comparators on Acinetobacter spp. isolates collected from patients with bacteremia and MIC change during the Tigecycline Evaluation and Surveillance Trial, 2004 to 2008.

21 January 2018

1 reference

In vitro activity of tigecycline against carbapenemase-producing Acinetobacter baumannii

21 January 2018

1 reference

Antimicrobial treatment and clinical outcomes of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia

21 January 2018

1 reference

In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.

21 January 2018

1 reference

Efficacy of tigecycline vs. imipenem in the treatment of experimental Acinetobacter baumannii murine pneumonia.

21 January 2018

1 reference

Clinical experience with tigecycline in the treatment of carbapenem-resistant Acinetobacter infections

21 January 2018

1 reference

A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline

21 January 2018

1 reference

Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence

21 January 2018

1 reference

Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline

21 January 2018

1 reference

A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae

21 January 2018

1 reference

Prevalence of antibiotics resistance and OXA carbapenemases genes in multidrug-resistant Acinetobacter baumannii isolates in central Taiwan

21 January 2018

1 reference

Pharmacodynamic assessment of Amoxicillin-Sulbactam against Acinetobacter baumannii: searching the optimal dose and infusion time through a human ex-vivo model

21 January 2018

1 reference

Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia

21 January 2018

1 reference

Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.

21 January 2018

1 reference

In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases

21 January 2018

1 reference

Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events.

21 January 2018

1 reference

Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii

21 January 2018

1 reference

Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections

21 January 2018

1 reference

Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.

21 January 2018

1 reference

In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli

21 January 2018

1 reference

Quantitative assessment of combination antimicrobial therapy against multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies

21 January 2018

1 reference

Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control.

21 January 2018

1 reference

Current control and treatment of multidrug-resistant Acinetobacter baumannii infections

21 January 2018

1 reference

Control of an outbreak of multi-drug-resistant Acinetobacter baumannii in an intensive care unit and a surgical ward

21 January 2018

1 reference

Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC Position paper .

21 January 2018

1 reference

In vitro activity of doripenem against Acinetobacter baumannii clinical isolates

21 January 2018

1 reference

Activity of doripenem with and without levofloxacin, amikacin, and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii

21 January 2018

1 reference

In vitro activity of ceftobiprole against Acinetobacter baumannii clinical isolates.

21 January 2018

1 reference

Encapsulation in fusogenic liposomes broadens the spectrum of action of vancomycin against Gram-negative bacteria.

21 January 2018

1 reference

Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii

21 January 2018

1 reference

In vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant gram-negative bacilli

21 January 2018

1 reference

Activity of the investigational fluoroquinolone finafloxacin against ciprofloxacin-sensitive and -resistant Acinetobacter baumannii isolates

21 January 2018

1 reference

Novel bis-indole agents active against multidrug-resistant Acinetobacter baumannii.

21 January 2018

1 reference

Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections.

21 January 2018

1 reference

In vitro bactericidal activity of human beta-defensin 2 against nosocomial strains.

21 January 2018

1 reference

Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens.

21 January 2018

1 reference

Comparative analysis of the bactericidal activities of amphibian peptide analogues against multidrug-resistant nosocomial bacterial strains.

21 January 2018

1 reference

Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-beta-naphthylamide

21 January 2018

1 reference

Tackling antibiotic resistance: a dose of common antisense?

21 January 2018

1 reference

Inhibition of gene expression and growth by antisense peptide nucleic acids in a multiresistant beta-lactamase-producing Klebsiella pneumoniae strain

21 January 2018

1 reference

Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii

21 January 2018

1 reference

AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus–Acinetobacter baumannii complex

21 January 2018

1 reference

Panresistant extended-spectrum β-lactamase SHV-5-producing Acinetobacter baumannii from New York City

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/FMB.11.23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21526942%20AND%20SRC:MED&resulttype=core&format=json

release_ggymhtfjxzfbhavulnqpw23mkq

30 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ggymhtfjxzfbhavulnqpw23mkq

24 November 2022

mapped directly with Wikidata item

1 reference